OLD National Bancorp IN Sells 10,055 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

OLD National Bancorp IN lowered its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 24.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 30,306 shares of the pharmacy operator’s stock after selling 10,055 shares during the quarter. OLD National Bancorp IN’s holdings in Walgreens Boots Alliance were worth $272,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Iron Horse Wealth Management LLC increased its holdings in Walgreens Boots Alliance by 162.5% during the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 1,300 shares during the period. Blue Trust Inc. grew its position in shares of Walgreens Boots Alliance by 87.0% in the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 1,081 shares during the last quarter. Continuum Advisory LLC increased its stake in shares of Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 1,020 shares during the period. Strategic Investment Solutions Inc. IL bought a new position in shares of Walgreens Boots Alliance during the second quarter valued at approximately $34,000. Finally, New Covenant Trust Company N.A. purchased a new stake in Walgreens Boots Alliance in the first quarter worth $35,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 3.9 %

Shares of Walgreens Boots Alliance stock opened at $9.35 on Thursday. The company has a 50-day simple moving average of $9.37 and a two-hundred day simple moving average of $12.91. Walgreens Boots Alliance, Inc. has a 52-week low of $8.22 and a 52-week high of $27.05. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.31 and a current ratio of 0.68. The stock has a market capitalization of $8.07 billion, a PE ratio of -1.39, a price-to-earnings-growth ratio of 1.37 and a beta of 0.70.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.03. The business had revenue of $37.50 billion for the quarter, compared to analysts’ expectations of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm’s quarterly revenue was up 5.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.67 EPS. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.57 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. JPMorgan Chase & Co. reduced their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Barclays increased their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 16th. Truist Financial cut their price objective on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. Evercore ISI increased their target price on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 16th. Finally, TD Cowen lowered their target price on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research note on Tuesday. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus target price of $12.88.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.